Marie Moores
BioInvent's CEO expects an eventful 2023
In 2022, biotechnology company BioInvent demonstrated its ability to attract both capital and new collaborations. The company also advanced several of its...
Intervju
BioInvent delivered in 2021 with more to come in 2022
The Swedish biotechnology company BioInvent recently published its year-end report,...
Intervju
BioInvent strengthens the organization with COO
Swedish biotechnology company BioInvent strengthened its pipeline of...
Intervju